Medicus Pharma Ltd. (MDCX) is a biotechnology company specializing in non-invasive skin cancer treatments, with low debt and liquidity ratios supporting financial compliance. However, insufficient income data leads to some review statuses. The company is not included in any major Shariah indices, resulting in a non-compliant overall status. Core business activities are permissible, with no controversies or non-compliant revenue sources identified. Investors should monitor for improved data transparency and potential index inclusion as the company grows.